Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39393026

Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2025 Jan
First author
Galsky MD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Androl Urol. 2025 Oct 31;14(10):2786-2791. doi: 10.21037/tau-2025-567.
    note
    Source null
    related pmid
    41230171
    relationship
    Comment in
  2. citation
    Transl Androl Urol. 2026 Jan 31;15(1):6. doi: 10.21037/tau-2025-aw-749.
    note
    Source null
    related pmid
    41658450
    relationship
    Comment in

Authors and identifiers

  1. name
    Galsky MD
    type
    Author
  2. name
    Witjes JA
    type
    Author
  3. name
    Gschwend JE
    type
    Author
  4. name
    Milowsky MI
    type
    Author
  5. name
    Schenker M
    type
    Author
  6. name
    Valderrama BP
    type
    Author
  7. name
    Tomita Y
    type
    Author
  8. name
    Bamias A
    type
    Author
  9. name
    Lebret T
    type
    Author
  10. name
    Shariat SF
    type
    Author
  11. name
    Park SH
    type
    Author
  12. name
    Agerbaek M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Galsky MD
    type
    Author
  2. name
    Witjes JA
    type
    Author
  3. name
    Gschwend JE
    type
    Author
  4. name
    Milowsky MI
    type
    Author
  5. name
    Schenker M
    type
    Author
  6. name
    Valderrama BP
    type
    Author
  7. name
    Tomita Y
    type
    Author
  8. name
    Bamias A
    type
    Author
  9. name
    Lebret T
    type
    Author
  10. name
    Shariat SF
    type
    Author
  11. name
    Park SH
    type
    Author
  12. name
    Agerbaek M
    type
    Author
bibliography ids
  1. nci-bib-bbb380ae046fa08670c32439
book metadata
content sha256
5891e3ae85b814b8d608677ca2a541167a87fef1d1239d65b809ddad08bcda0c
document type
citation
dois
  1. 10.1200/JCO.24.00340
electronic publication date
display
2024 Oct 11
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:39393026
immutable id
pubmed:39393026@5891e3ae85b814b8d608677ca2a541167a87fef1d1239d65b809ddad08bcda0c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
15-21
volume
43
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Androl Urol. 2025 Oct 31;14(10):2786-2791. doi: 10.21037/tau-2025-567.
    note
    Source null
    related pmid
    41230171
    relationship
    Comment in
  2. citation
    Transl Androl Urol. 2026 Jan 31;15(1):6. doi: 10.21037/tau-2025-aw-749.
    note
    Source null
    related pmid
    41658450
    relationship
    Comment in
outcomes validated
false
pmid
39393026
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
1a005bcde1788acf68b5cedd5db3c348f819487a11014f0d3ae9583d145cc2ec
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2025 Jan
precision
month
year
2025
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Research Support, Non-U.S. Gov't
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39393026/
title
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.

Preserved source evidence · Not medical advice